Table 1.
Clinical characteristics Of PE patients
| Entire Cohort | Low risk | Intermediate risk | High risk | P value | |
|---|---|---|---|---|---|
| Number of admissions (N= 429) | 429 | 163 | 256 | 10 | |
| Mean age in years (range 20–98) |
64.5 (SD 15.96) |
61.2 (SD 15.8) |
66.9 (SD 15.7) |
57.8 (SD 14.8) |
< 0.001a |
| Females |
209 (48.7%) |
87 (53.3%) |
119 (46.5%) |
3 (30%) |
0.2b |
| History of malignancy |
189 (44.0%) |
82 (50.3%) |
106 (41.4%) |
1 (10%) |
0.01b |
| Active malignancy |
158 (36.8%) |
64 (39.3%) |
93 (36.3%) |
1 (10%) |
0.1b |
| Pulmonary Embolism Severity Index |
112 (SD 37.7) |
95.8 (SD 32.0) |
119 (SD 34.4) |
200 (SD 28.1) |
< 0.001a |
| Positive cardiac troponin T |
212 (49.4%) |
0 | 204 (79.7%) |
8 (80%) |
|
| Positive NTproBNP |
159 (37.1%) |
0 |
156 (60.9%) |
3 (30%) |
|
| Right ventricular dysfunction |
148 (34.5%) |
0 |
138 (53.9%) |
10 (100%) |
|
| Ultrasound examinations for extremity deep venous thrombosis |
331 (77.1%) |
123 (75.5%) |
199 (77.7%) |
9 (90%) |
0.7a |
| Positive deep venous thrombosis (% of ultrasound examinations) |
209 (63.1%) |
68 (55.3%) |
137 (68.8%) |
4 (44.4%) |
0.01a |
| Hospital length of stay (mean, median, SD) | 6.3, 4.0, 8.7 | 6.1, 3.0, 10.8 | 6.2, 4, 7.1 | 11.0, 7.0, 10.4 | 0.22b |
| ICU length of stay | 0.89, 0, 2.2 | 0.42, 0, 1.3 | 0.99, 0, 2.0 | 5.7, 2.5, 7.7 | < 0.001b |
aOne-way ANOVA
bChi-square 3-sample test for equality of proportions